Stockscreener 앱 받기
1.50
4.17%
0.06
시간 외 거래:
1.46
-0.04
-2.67%
전일 마감가:
$1.44
열려 있는:
$1.46
하루 거래량:
183.82K
Relative Volume:
0.78
시가총액:
$136.53M
수익:
-
순이익/손실:
$1.60M
주가수익비율:
50.00
EPS:
0.03
순현금흐름:
$-62.91M
1주 성능:
+1.35%
1개월 성능:
-11.76%
6개월 성능:
-41.63%
1년 성능:
-14.29%
1일 변동 폭
$1.45
$1.50
1주일 범위
$1.44
$1.52
52주 변동 폭
$1.13
$2.66
Compugen Ltd Stock (CGEN) Company Profile
CGEN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CGEN
Compugen Ltd
|
1.50 | 136.53M | 0 | 1.60M | -62.91M | 0.03 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Compugen Ltd Stock (CGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-13 | 개시 | Oppenheimer | Outperform |
| 2022-08-05 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-05-26 | 재개 | JMP Securities | Mkt Outperform |
| 2020-05-13 | 개시 | Stifel | Buy |
| 2020-05-07 | 개시 | SVB Leerink | Outperform |
| 2020-04-22 | 개시 | ROTH Capital | Buy |
| 2020-03-24 | 개시 | SunTrust | Buy |
| 2020-01-16 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-03-29 | 개시 | Oppenheimer | Outperform |
| 2016-02-01 | 재개 | Oppenheimer | Outperform |
| 2015-10-15 | 개시 | FBR Capital | Outperform |
| 2015-04-23 | 재개 | Jefferies | Buy |
| 2015-04-21 | 개시 | Oppenheimer | Outperform |
| 2014-02-07 | 개시 | MLV & Co | Buy |
| 2009-12-28 | 재확인 | Cantor Fitzgerald | Buy |
| 2009-07-29 | 개시 | Cantor Fitzgerald | Buy |
모두보기
Compugen Ltd 주식(CGEN)의 최신 뉴스
Real time pattern detection on Compugen Ltd. stockFree Access to Real-Time Trade Insights - Newser
Can Compugen Ltd. hit a new high this monthFree Weekly Return Pick Forecast Reports - Newser
Compugen Ltd. stock prediction for this weekMarket Correction Proof Stock Screening Analysis - Newser
Compugen signals leadership transition and advances COM701 ovarian cancer trial with interim data targeted for 2026 - MSN
Need To Know: Analysts Just Made A Substantial Cut To Their Compugen Ltd. (NASDAQ:CGEN) Estimates - Yahoo Finance
Using portfolio simulators with Compugen Ltd. includedBuy Point Strategy with Profit Protection - Newser
How Compugen Ltd. stock performs during market volatilityPredictive Short-Term Market Reversal Alerts - Newser
Compugen (NASDAQ:CGEN) Downgraded by Wall Street Zen to Sell - Defense World
Using Bollinger Bands to evaluate Compugen Ltd.Free Capital Protection Trading Strategies - Newser
Using data tools to time your Compugen Ltd. exitForecast Model for Intraday Buy Signals - Newser
Understanding Compugen Ltd.’s price movementFree Weekly Hot Picks With Buy Confidence - Newser
How Efficient Is Compugen Ltd. at Controlling Operating CostsMarket Timing Strategy with Technical Filters - Newser
Compugen Reports Q2 2025 Earnings with Strategic Progress Amid Financial Challenges - AInvest
Compugen Reports Q2 Earnings: Revenue Down, Net Loss Up, and Ovarian Cancer Competition Rises Amid Strong Partnerships and Cash Reserves - AInvest
Compugen (CGEN) Gets a Buy from Leerink Partners - The Globe and Mail
Compugen Ltd. (NASDAQ:CGEN) Q2 2025 Earnings Call Transcript - Insider Monkey
Compugen's COM701 Shifts Focus to Targeting PSOC Patients, With Multiple Catalysts Ahead - AInvest
Compugen: Potential Best-In-Class Anti-PVRIG COM701 Shifts To Targeting PSOC Patients - Seeking Alpha
Will Compugen Ltd. Stock Benefit from AI and Green Energy TrendsRSI and MACD Signal Summary with Trends - Newser
Compugen Ltd. stock momentum explainedFree ROI Boosting Trade Opportunity Calendar - Newser
Compugen’s COM701 Trial: A Potential Game-Changer in Ovarian Cancer Treatment? - TipRanks
Compugen price target raised to $13 from $10 at Leerink - TipRanks
Compugen Reports Q2 2025 Results and Advances in Immuno-Oncology Trials - The Globe and Mail
Compugen stock price target raised to $13 from $10 at Leerink Partners - Investing.com Australia
Is Compugen Ltd. stock entering bullish territoryReliable Setup Screener with Low Risk - Newser
Compugen Reports Q2 2025 Results and Strategic Progress - TipRanks
Advanced analytics toolkit walkthrough for Compugen Ltd.Trading Watchlist with Real Time Filters - Newser
Compugen Ltd. recovery potential after sell offInvestment Position Summary with Timeframe Forecast - Newser
Intrinsic Value of Compugen Ltd. Stock: Is It Undervalued or OvervaluedFree Wealth Building Stock Market Ideas - Newser
Real time scanner hits for Compugen Ltd. explainedPrice Spike Prediction for Active Traders - Newser
Compugen Ltd. shares fall 1.37% intraday after Q2 2025 earnings call. - AInvest
Compugen Ltd reports results for the quarter ended June 30Earnings Summary - TradingView
Compugen (CGEN) Reports Q2 Loss, Lags Revenue Estimates - sharewise.com
Compugen Reports Q2 Loss, Misses Revenue Estimates - AInvest
Compugen Announces 2025 Annual General Meeting: Election of Directors and Financial Oversight on Agenda - AInvest
Compugen Ltd. Announces 2025 Annual General Meeting Details - TipRanks
Compugen: Q2 Earnings Snapshot - San Antonio Express-News
Technical signs of recovery in Compugen Ltd.Watchlist Generator for Smart Money Signals - Newser
Can Compugen Ltd. recover in the next quarterWatchlist Generator With Real-Time Entry - Newser
Compugen earnings missed by $0.02, revenue fell short of estimates - Investing.com South Africa
Compugen Q2 Earnings Miss Estimates, Revenue Down 80.6% YoY - AInvest
Compugen Q2 Earnings: $94M Cash Runway Powers Multiple Cancer Drug Trials, ESMO Data Coming - Stock Titan
Compugen Ltd. stock retracement – recovery analysisReal Time Alert System for Market Moves - Newser
Evaluating Compugen Ltd. with trendline analysisBuy and Exit Strategy Based on Momentum - Newser
How institutional ownership impacts Compugen Ltd. stockFree Accurate Buy Point for Momentum Stocks - Newser
Why Compugen Ltd. stock attracts strong analyst attentionFree Step-by-Step Trade Signal Implementation - Newser
How to read the order book for Compugen Ltd.Short Term Opportunity Finder with Tools - Newser
Compugen Ltd expected to post a loss of 6 cents a shareEarnings Preview - TradingView
Compugen (CGEN) to Release Earnings on Wednesday - Defense World
Compugen Ltd. Breakout Confirmed by Volume MetricsSmart Investment Tips Gaining Popularity Among Analysts - metal.it
Buy Signal for Compugen Ltd. Stock Key Technical Indicators to WatchFree Weekly Stock Opportunity Radar Scanner - Newser
Compugen Ltd (CGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):